Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09.

Dillman, Robert O

Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09. [electronic resource] - Cancer biotherapy & radiopharmaceuticals Apr 2006 - 130-7 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1084-9785

10.1089/cbr.2006.21.130 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Carcinoma, Renal Cell--drug therapy
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Injections, Subcutaneous
Interferon alpha-2
Interferon-alpha--administration & dosage
Interleukin-2--administration & dosage
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Recombinant Proteins